The Role of Amifostine as a Radioprotectant in the Management of Patients with Squamous Cell Head and Neck Cancer A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO)

Evidence-Based Series 5-2 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) The Role of Endolaryngeal Surgery (With or Without Laser) versus Radiotherapy in the Management of Early (T1) Glottic Cancer

Evidence Summary Report 4-6a EDUCATION AND INFORMATION 2014 A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Screening Postmenopausal Women for Ovarian Cancer

Evidence-based Series 4-14 EDUCATION AND INFORMATION 2015 A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Adjuvant Hormonal Therapy for Stage I Endometrial Cancer

Soluble HER-2 in Patients with Head and Neck Squamous Cell Carcinoma

Introduction: The presence of HER-2 has been shown to be a prognostic factor in many kinds of cancers, but its role in head and neck squamous cell carcinoma (HNSCC) is not still defined. The purpose of the current study is to investigate the role of HER-2 in HNSCC and its correlation with various clinicopathologic parameters.   Materials and Methods: Peripheral blood samples were obtained ...

Practice Guideline Report 13-2 EDUCATION AND INFORMATION 2013 A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Radiotherapy Fractionation for the Palliation of Uncomplicated Painful Bone Metastases